CERO THERAPEUTICS HOLDINGS INC reports a Return on Equity (ROE) of 223.57%.

What is CEROW's dividend yield?

CERO THERAPEUTICS HOLDINGS INC offers a dividend yield of 0.00%.

What is CEROW's Deepscope Quality Score?

Deepscope rates CEROW's overall financial quality at 38 out of 100, based on profitability, growth, debt and earnings stability.

Is now a good time to buy CEROW?

Deepscope's AI Timing Score for CEROW is 2 out of 100, indicating the relative attractiveness of buying at the current price using technical and momentum signals.

CEROW (NASDAQ) 株価分析 | CERO THERAPEUTICS HOLDINGS INC

Stock Check Daily update data at 9:30 AM
(Price: 2026-06-03 | FS: 2026-03-31)

CEROW

CERO THERAPEUTICS HOLDINGS INC

US:NASDAQ STOCK News 93

USD 0.00

0 (0%) Day Change

Watchlist Portfolio Compare Chart

-0.06

D/E

223.6%

ROE

-938.7%

ROA

0.00%

Div Yield

CERO THERAPEUTICS HOLDINGS INC
TYPE: STOCK
MARKET: NASDAQ

Compare Watchlist Myport

USD 0.00 Price 0 (0%) Day Change	NEWS SCORE: 93

CEROW, ファンダメンタルスコアはnot good ( ファンダメンタル = 38) そしてテクニカルスコアは ...(Sign In to See)...

No price data to display chart for the last 3-months of this stock

38 QUALITY

Signal: UNDERPERFORM

Signal Description: Company financial health is Not Good

Reason: ROAが低い
昨年度のROEが一昨年比で低い
ROEが昨年度比で低い
ROAがROEに比べて低い
Last-year ROA is lower than last-2-years ROA.
昨年度のROAが一昨年比で低い
NPMが低い
NPMの伸びが低い

88 Sign in

TIMING

Signal: OUTPERFORM

Signal Descri...: Good

Reason: Lorem ipsum dolor sit amet

Unlock timing signals and detailed reasons

In details, quality factors are not quite good , financial health is not good , and ability to make profit is not good , ...

Deepscope 分析

51%

In Recommendations?	Not in any sections
Select Rate	0.00 From 30 days period
Watch Rate	0.00 From 30 days period
News Score	93
Magic Formula Rank by ROA	N/A
Magic Formula Rank by ROE	N/A
Magic Formula Rank by ROIC	N/A
Price	N/A
PBV / Sector	N/A / N/A
Earning Per Share	N/A

PE / Sector	N/A / N/A
PEG or PE/Growth / Sector	N/A / N/A
Average 1M Daily Value	73.634685000000 GOOD
Average 1W Daily Value	37.922000000000 GREAT

Timing Factors

57%

MACD	SIGN IN
MACD Signal	SIGN IN
MACD Divergence	SIGN IN
RSI	SIGN IN
Stochastic Oscillator K	SIGN IN
Stochastic Oscillator D	SIGN IN
ADX	SIGN IN
Avg 5 day Timing Score	SIGN IN

Financial Health

37%

DE / Sector	SIGN IN
DE Average / Sector	SIGN IN
DE Change Average (%) / Sector	SIGN IN
Current Ratio / Sector	SIGN IN
Current Ratio Average / Sector	SIGN IN
Current Ratio Change Average (%) / Sector	SIGN IN
Quick Ratio / Sector	SIGN IN
Quick Ratio Average / Sector	SIGN IN
Quick Ratio Change Average (%) / Sector	SIGN IN
FCF/Share / Sector	SIGN IN
FCF/Share Average / Sector	SIGN IN
FCF/Share Change Average (%) / Sector	SIGN IN

ポイントになる統計

37%

GPM (%) / Sector	SIGN IN
GPM Average (%) / Sector	SIGN IN
GPM Change Average (%) / Sector	SIGN IN
OPM (%) / Sector	SIGN IN
OPM Average (%) / Sector	SIGN IN
OPM Change Average (%) / Sector	SIGN IN
NPM (%) / Sector	N/A / N/A
NPM Average (%) / Sector	N/A / N/A
NPM Change Average (%) / Sector	N/A / N/A
Asset Turnover / Sector	SIGN IN
Asset Turnover Average / Sector	SIGN IN
Asset Turnover Change Average (%) / Sector	SIGN IN
ROA (%) / Sector	-938.74 / N/A
ROA Average (%) / Sector	-322.41 / N/A
ROA Change Average (%) / Sector	63,005.55 / N/A GREAT
ROE (%) / Sector	223.57 / N/A GREAT
ROE Average (%) / Sector	194.09 / N/A GREAT
ROE Change Average (%) / Sector	231,788.09 / N/A GREAT
ROIC (%) / Sector	SIGN IN
ROIC Average (%) / Sector	SIGN IN
ROIC Change Average (%) / Sector	SIGN IN

配当

Dividend (%) / Sector	N/A / N/A
Dividend Average (%) / Sector	N/A / N/A
Dividend Change Average (%) / Sector	N/A / N/A

登録情報

Analyze Date	2026-06-04 09:24:24
Symbol	CEROW
Name	CERO THERAPEUTICS HOLDINGS INC
Sector
Market	NASDAQ
Listed Shares	0.00
Par Value	N/A
Calculated From	Quarter
Sign	N/A
Market Cap (M.USD) / Sector Average	N/A / N/A

ニュース

Estimation Consensus	See at WSJ.com
Full details	See at WSJ.com
Chart	See in Chart feature
News	See at Yahoo Finance

Address: 201 Haskins Way, South San Francisco, CA, United States, 94080

Phone: 650 407 2376

Website: https://www.cero.bio

Sector: -

Description: CERo Therapeutics Holdings, Inc., an immunotherapy company, engages in the development of engineered T cell therapeutics for the treatment of cancer. The company's lead development candidate is CER-1236, an autologous T cell therapy candidate for the treatment of hematologic malignancies and solid tumors. The company was incorporated in 2021 and is based in South San Francisco, California.